No Benefit for Lopinavir–Ritonavir in Severe COVID-19

Published on:

Treatment with the HIV combination drug lopinavir-ritonavir did not accelerate recovery or improve mortality rates among hospitalized patients with severe coronavirus disease 2019 (COVID-19), a trial in the New England Journal of Medicine reported.

Read more    Source: jamanetwork.com

Leave a Reply